DESCRIPTION: (Adapted from Investigator's Abstract) The MCS was established
in 1984 to evaluate the natural history of HTLV-I in two endemic communities
in southwestern Japan; the prevalence of infection is currently 27% among
the nearly 2000 participants. It was recently discovered that one of these
communities also has a prevalence of HCV of about 26%. The plan is to
extend and expand the preliminary studies on the natural history of HCV, to
consolidate the work on the natural history of HTLV-I, and to evaluate the
effect of co-infection of these two newly identified viruses. Specifically,
the application proposes: to describe the pattern and distribution of
seromarkers of HCV infection; to examine the stability of markers within the
host, over time; to develop an operational definition of HCV infection; to
evaluate the relevance of various HCV seromarkers with respect to liver
function over time and in relation to reported liver disease; to investigate
the effect of HCV infection on overall and cause-specific morbidity and
mortality; to evaluate whether there is evidence that HCV infection is
immunosuppressive; to describe the viral marker profiles in subjects
co-infected with both HCV and HTLV-I; to identify the HTLV-I viral markers
and demographic risk factors predictive of proviral clonality among
carriers; to evaluate the interaction of HTLV-I infection and Helicobacter
pylori in the risk of peptic ulcer and of gastric cancer; to describe the
evolution of HTLV-I parameters in seroconvertors and to identify additional
viral correlates of transmission from infected spouses; to evaluate the
levels of various soluble T-cell surface markers as an index of viral
status.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.